Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524610 · ClinicalTrials.gov registry record · NA
Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer
A NA study of Pediatric Cancer and Survivorship, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 205
- Enrollment target
- 2
- Study locations
NCT05524610: Recruiting NA study of Pediatric Cancer and Survivorship, sponsored by University of Colorado, Denver.
NCT05524610 is a NA study of Pediatric Cancer and Survivorship that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 205 participants, below the 1,486-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05524610, a NA study of Pediatric Cancer and Survivorship, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 205 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prior research determined adolescent and young adult-aged childhood cancer survivor (AYA-CCS) and medical provider acceptability of the SexFS Brief in a controlled research setting. Development of an acceptable, effective, and feasible screening approach will result in improved recognition of SD in AYA patients with and surviving childhood cancer.
Primary Outcome
Comparison of pre- and post- intervention percentage of patients reporting that his/her provider has communicated with them about sexual function Subjects will report (yes or no) via survey after their healthcare visit.
Conditions Studied
Interventions
- BEHAVIORAL Sexual Function Screening Approach
Study Locations (2)
Colorado
- Childrens Hospital Colorado - Aurora
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05524610 shows while recruiting
NCT05524610 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 1,486-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Sexual Function Screening Approach is the first listed.
NCT05524610 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05524610 about?
NCT05524610 is a clinical study titled "Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer". Prior research determined adolescent and young adult-aged childhood cancer survivor (AYA-CCS) and medical provider acceptability of the SexFS Brief in a controlled research setting. Development of an acceptable, effective, and feasible screening approach will result in improved recognition of SD in ...
What is the current status of trial NCT05524610?
This trial is currently recruiting. It is a NA study. The enrollment target is 205 participants. The study started on 2023-02-14. Estimated completion is 2027-06-30.
What conditions does trial NCT05524610 study?
This clinical trial studies the following conditions: Pediatric Cancer, Survivorship.
What interventions are being tested in trial NCT05524610?
The interventions under investigation include: Sexual Function Screening Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT05524610?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05524610 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05524610's enrollment target sits among peer trials
205 15th of 51 higher than 37 of 51 other Pediatric Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multisite Implementation of COMPRENDO
RECRUITING · NA
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
RECRUITING · NA
-
Digital Art Therapy for Young Cancer Survivors
RECRUITING · NA
-
Medically Tailored Meals for Kids
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI